Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma

Larry E. Puls, Deborah E. Powell, Paul D. DePriest, Holly H. Gallion, James E. Hunter, Richard J. Kryscio, J. R. Van Nagell

Research output: Contribution to journalArticlepeer-review

162 Scopus citations


The slides of all patients with ovarian cystadenocarcinoma treated at the University of Kentucky Medical Center from 1966-1990 were reviewed. Fifty-four serous tumors and 42 mucinous neoplasms were identified for further study. Benign epithelium adjacent to an area of borderline or malignant epithelium was observed in 74 tumors (79%) and a site of epithelial transition was noted in 38 cases (40%). The presence of associated benign epithelium was more common in borderline or well-differentiated lesions and in patients with early-stage disease. These findings are consistent with epidemiologic and molecular genetic data and suggest that certain benign serous or mucinous ovarian tumors have the potential for malignant transformation. Removal of these tumors, particularly in postmenopausal women, should result in a subsequent reduction in the frequency of ovarian cancer.

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalGynecologic Oncology
Issue number1
StatePublished - Oct 1992

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology


Dive into the research topics of 'Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma'. Together they form a unique fingerprint.

Cite this